###begin article-title 0
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 75 80 <span type="species:ncbi:9606">human</span>
NotI flanking sequences: a tool for gene discovery and verification of the human genome
###end article-title 0
###begin p 1
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 229 232 229 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 374 377 374 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 529 532 529 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 563 566 563 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 807 810 805 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 930 933 928 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 329 334 <span type="species:ncbi:9606">human</span>
###xml 498 503 <span type="species:ncbi:9606">human</span>
###xml 732 737 <span type="species:ncbi:9606">human</span>
###xml 894 899 <span type="species:ncbi:9606">human</span>
A set of 22 551 unique human NotI flanking sequences (16.2 Mb) was generated. More than 40% of the set had regions with significant similarity to known proteins and expressed sequences. The data demonstrate that regions flanking NotI sites are less likely to form nucleosomes efficiently and resemble promoter regions. The draft human genome sequence contained 55.7% of the NotI flanking sequences, Celera's database contained matches to 57.2% of the clones and all public databases (including non-human and previously sequenced NotI flanks) matched 89.2% of the NotI flanking sequences (identity >/=90% over at least 50 bp, data from December 2001). The data suggest that the shotgun sequencing approach used to generate the draft human genome sequence resulted in a bias against cloning and sequencing of NotI flanks. A rough estimation (based primarily on chromosomes 21 and 22) is that the human genome contains 15 000-20 000 NotI sites, of which 6000-9000 are unmethylated in any particular cell. The results of the study suggest that the existing tools for computational determination of CpG islands fail to identify a significant fraction of functional CpG islands, and unmethylated DNA stretches with a high frequency of CpG dinucleotides can be found even in regions with low CG content.
###end p 1
###begin p 2
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
DDBJ/EMBL/GenBank accession nos+ To whom correspondence should be addressed at: Microbiology and Tumor Biology Center, Karolinska Institute, Box 280, 171 77 Stockholm, Sweden. Tel: +46 8 728 6750; Fax: +46 8 319 470; Email: The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors AQ936570-AQ939834, AJ322533-AJ343893
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 60 61 60 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c1">1</xref>
###xml 62 63 62 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c2">2</xref>
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c1">1</xref>
###xml 327 328 327 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c1">1</xref>
###xml 329 330 329 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c4">4</xref>
###xml 633 636 633 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 679 684 <span type="species:ncbi:9606">human</span>
Draft sequences of the human genome were recently reported (1,2). Much work remains to be done to produce a complete finished sequence and progress can be best assured by a diversity of approaches (1). At present, one of the principal goals for genome research is a careful and systematic validation of the assembled sequence (1-4). In this respect it becomes critically important to develop and to apply strategies capable of fulfilling this crucial aim. These strategies should exploit approaches independent of those used to generate the original genome sequence. Short sequences flanking the rare restriction sites, for instance NotI, might serve as a tool for validation of human genome structure.
###end p 4
###begin p 5
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 65 68 65 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 94 97 94 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 165 168 165 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 265 266 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c5">5</xref>
###xml 267 268 267 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c6">6</xref>
###xml 282 285 282 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 411 412 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c7">7</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c13">13</xref>
###xml 486 489 486 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 503 506 503 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 625 628 625 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 663 664 663 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c7">7</xref>
###xml 665 667 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c15">15</xref>
###xml 392 397 <span type="species:ncbi:9606">human</span>
###xml 619 624 <span type="species:ncbi:9606">human</span>
NotI linking clones contain pairs of sequences flanking a single NotI recognition site, while NotI jumping clones contain DNA sequences spanning between neighboring NotI restriction sites. Such clones were shown to be tightly associated with CpG islands and genes (5,6). The use of NotI linking and jumping clones as framework markers was proposed to define the structure of large regions of human chromosomes (7-13). To achieve this goal, simplified procedures for the construction of NotI jumping and NotI linking libraries were developed and a number of chromosome 3-specific and other chromosome-specific and total human NotI linking libraries were prepared (7-15).
###end p 5
###begin p 6
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 87 88 87 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c6">6</xref>
###xml 302 309 302 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 431 432 431 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c6">6</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c13">13</xref>
###xml 443 446 443 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c14">14</xref>
###xml 771 772 771 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c6">6</xref>
###xml 813 815 813 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c13">13</xref>
###xml 816 818 816 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c15">15</xref>
###xml 827 830 827 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 13 18 <span type="species:ncbi:9606">human</span>
###xml 499 504 <span type="species:ncbi:4932">yeast</span>
One thousand human chromosome 3-specific NotI linking clones were partially sequenced (6). Among these, 249 unique clones were identified and 152 were carefully analyzed. To localize these clones, PCR, Southern hybridization, pulsed field gel electrophoresis (PFGE) and two- or three-color fluorescent in situ hybridization (FISH) were applied. In many cases, chromosome jumping was successfully used to resolve ambiguous mapping (6,13). This NotI map was compared to the chromosome 3 map, based on yeast artificial chromosome clones and radiation hybrids (14), and significant differences in several chromosome 3 regions were noticed. Importantly, these differences included a 3p14-p22 region with homozygous deletions and most likely containing tumor suppressor genes (6). These data supported earlier notions (13,15) that a NotI physical map can be more informative than genetic or radiation hybrid maps.
###end p 6
###begin p 7
###xml 46 49 46 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 109 112 109 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 161 164 161 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 184 187 184 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 310 313 310 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 363 366 363 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 449 450 449 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c9">9</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c16">16</xref>
###xml 633 636 633 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 1025 1028 1011 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 1077 1080 1063 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 1152 1154 1138 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c17">17</xref>
###xml 1155 1157 1141 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c22">22</xref>
###xml 328 333 <span type="species:ncbi:9606">human</span>
###xml 436 441 <span type="species:ncbi:9606">human</span>
To enable a direct assessment of the value of NotI clones in genome research, high-density grids with 50 000 NotI linking clones derived from six representative NotI linking and three NotI jumping libraries were constructed. Altogether, these libraries contained nearly 100 times the total estimated number of NotI sites in the human genome. Sequencing of 20 000 NotI clones was projected to provide information linked to 10-20% of all human genes (9) and may help in the identification of new genes. Before starting a large-scale project, a pilot study to validate the proposed strategy was performed (16). In that work 3265 unique NotI flanking sequences were generated. Analysis of sequences demonstrated that approximately50% of these clones displayed significant similarity to protein and cDNA sequences. Among these unique sequences, 1868 (57.2%) were novel sequences, not present in the EMBL or expressed sequence tag (EST) databases (similarity </=90% over 50 bp). The work also showed tight, specific association of NotI sites with the first exons of genes. From that NotI resource several new genes have been identified, isolated and mapped (17-22).
###end p 7
###begin p 8
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 124 127 112 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
As the pilot experiments confirmed expectations, the sequencing of NotI clones was continued and approximately22 500 unique NotI sequences were generated. This work provides the initial analysis of these data.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
General methods
###end title 10
###begin p 11
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c23">23</xref>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c16">16</xref>
Common molecular and microbiological methods were performed according to standard procedures (23). Plasmid DNA was isolated using a Biorobot 9600 (Qiagen) with REAL-prep kits according to the manufacturer's instructions. Sequencing gels were run on ABI 377 automated sequencers (PE Applied Biosystems) according to the manufacturer's protocols. Sequencing was done as described previously (16).
###end p 11
###begin title 12
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
NotI libraries, clone names and accession numbers
###end title 12
###begin p 13
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c10">10</xref>
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c16">16</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c24">24</xref>
###xml 352 355 352 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c16">16</xref>
###xml 196 201 <span type="species:ncbi:9606">human</span>
###xml 215 233 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 235 238 <span type="species:ncbi:10376">EBV</span>
###xml 312 315 <span type="species:ncbi:10376">EBV</span>
Construction of NotI linking and jumping libraries was as described (10,16). The CBMI-Ral-Sto cell line, selected for its unusually low level of methylation, was established by immortalization of human B cells with Epstein-Barr virus (EBV) strain B95-8 (24). Thus, the DNA isolated from this cell line contained EBV sequences. The nomenclature for the NotI linking libraries and clones used in this study is the same as in a previous work (16).
###end p 13
###begin p 14
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
The EMBL/GenBank accession numbers for the NotI sequences used in this work are AQ936570-AQ939834 and AJ322533-AJ343893.
###end p 14
###begin title 15
Sequence analysis
###end title 15
###begin p 16
The analysis of sequences was performed at the Karolinska Institute Sequence Analysis Center (kisac.cgr.ki.se), using local versions of programs and public databases.
###end p 16
###begin p 17
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c25">25</xref>
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c26">26</xref>
Protein and nucleotide similarity searches were performed with BLAST 2.0 (25,26). The high scoring segment pairs report cut-off (BLAST parameter -b) was restricted to 100 for protein and to 50 for nucleotide databases. The statistical significance threshold (BLAST parameter -e) was default (-e = 10) for the TREMBL (Translated EMBL) and SWISSPROT databases and for other databases searches was set to: EMBL and EST, -e = 1.E-10; Unigene (non-redundant set of gene-oriented clusters database), -e = 0.1; RefSeq (Reference Sequences) nucleotide and protein databases, -e = 0.001.
###end p 17
###begin p 18
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c27">27</xref>
MSPcrunch (version 2.4) was used to filter the BLAST program for selection of significant matches (27). This filtering ensures that domains with weak but significant hits will not be missed due to other higher scoring domains and 'junk' matches with biased composition are eliminated. Similarity data was sorted with MSPcrunch using default parameters (-B = 0.8 and 5, -C upper = 75, -C lower = 35 for protein alignments; -B = 0.8 and 5, -C upper = 140, -C lower = 90 for nucleotide alignments) and stringent (-B = 0.85 and 0, -C upper = 85, -C lower = 45 for protein alignments; -B 0.85 and 0, -C upper = 150, -C lower = 100 for nucleotide alignments).
###end p 18
###begin p 19
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c27">27</xref>
Default parameters were used to search the RefSeq, EST and Unigene databases. Stringent parameters were used for the EMBL, HTGS (High Throughput Genomic Sequences) and SWISSPROT + TREMBL databases. Empirical testing suggests that these parameters are effective in removing false matches (27).
###end p 19
###begin p 20
All short, simple and low complexity repeats were excluded from the analysis using RepeatMasker with the default minimum Smith-Waterman score of 225 ().
###end p 20
###begin p 21
###xml 68 73 <span type="species:ncbi:9606">human</span>
We used the RefSeq database release of December 2001 () with 14 300 human gene entries.
###end p 21
###begin p 22
###xml 22 25 22 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 351 352 351 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c1">1</xref>
###xml 353 354 353 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c2">2</xref>
###xml 357 360 357 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 328 333 <span type="species:ncbi:9606">human</span>
###xml 592 597 <span type="species:ncbi:9606">human</span>
Initial searches with NotI sequences were performed in June 2000 (EMBL database release 59, SWISSPROT database release 38, TREMBL database release 14) and December 2000 (EMBL database release 65, SWISSPROT database release 38, TREMBL database release 15). Additional comparisons were done in March 2001 against the draft of the human genome sequence (1,2). NotI sequences that failed to match to any of the above databases were searched again in June and December 2001 (EMBL database releases 67 and 69, SWISSPROT database releases 39 and 40, TREMBL database releases 17 and 19 and the draft human genome sequence).
###end p 22
###begin title 23
###xml 18 21 18 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 50 55 <span type="species:ncbi:9606">human</span>
Construction of a NotI sequence database from the human genome sequencing data
###end title 23
###begin p 24
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 118 121 118 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 232 235 232 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 337 340 337 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 388 391 388 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 83 88 <span type="species:ncbi:9606">human</span>
###xml 150 155 <span type="species:ncbi:9606">human</span>
In order to focus on NotI restriction sites within the large body of data from the human genome sequencing project, a NotI sequence database from the human genome sequencing data was constructed. Sequences (1 kb) extending out from NotI sites were taken from the HTGS database for subsequent analysis. We allowed for one mismatch to the NotI target sequence to ensure maximal coverage of NotI sites.
###end p 24
###begin p 25
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c28">28</xref>
The analysis of 1 kb NotI flanking sequences for nucleosome formation potential was performed as described (28).
###end p 25
###begin title 26
RESULTS AND DISCUSSION
###end title 26
###begin title 27
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
General characteristics of the NotI flanking sequences
###end title 27
###begin p 28
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 120 136 120 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 231 242 231 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudomonas</italic>
###xml 255 271 255 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 524 535 524 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudomonas</italic>
###xml 628 629 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c1">1</xref>
###xml 659 672 659 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Synechocystis</italic>
###xml 678 686 678 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus</italic>
###xml 695 707 695 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptomyces</italic>
###xml 858 859 858 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c1">1</xref>
###xml 903 904 903 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c1">1</xref>
###xml 905 907 905 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c29">29</xref>
###xml 120 136 <span type="species:ncbi:562">Escherichia coli</span>
###xml 159 177 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 179 182 <span type="species:ncbi:10376">EBV</span>
###xml 255 271 <span type="species:ncbi:562">Escherichia coli</span>
###xml 316 319 <span type="species:ncbi:10376">EBV</span>
###xml 345 350 <span type="species:ncbi:9606">human</span>
###xml 508 513 <span type="species:ncbi:9606">human</span>
###xml 589 594 <span type="species:ncbi:9606">human</span>
###xml 659 675 <span type="species:ncbi:1143">Synechocystis sp</span>
###xml 678 689 <span type="species:ncbi:1409">Bacillus sp</span>
###xml 786 791 <span type="species:ncbi:9606">human</span>
In this study 23 574 sequences flanking NotI sites were generated. Among them, 217 (0.9%) matched genomic sequences for Escherichia coli, 296 (1.3%) were from Epstein-Barr virus (EBV) and 131 (0.6%) sequences were most probably of Pseudomonas sp. origin. Escherichia coli DNA contaminated the vector preparation and EBV B95-8 was present in the human genomic DNA (see Materials and Methods). The level of identity in these matches was at least 90% over 100 bp. Therefore, 22 930 sequences were classified as human. However, Pseudomonas sp.-related sequences may be a real component of the human genome, as previously suggested (1). A few sequences related to Synechocystis sp., Bacillus sp. and Streptomyces sp. were also detected. Therefore, these data support the suggestion that the human genome contains sequences related to different bacterial species (1). The origin of such sequences is unclear (1,29).
###end p 28
###begin p 29
###xml 325 328 325 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 331 334 331 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 340 343 340 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 11 16 <span type="species:ncbi:9606">human</span>
Within the human subset, 379 (1.7%) redundant sequences were identified. Redundant sequences were defined as sequences sharing at least 99% identity over 360 bp of their length (this safeguard was used so as not to remove unique sequences that nevertheless have partial overlap due to common repeats or localization close to NotI, BamHI or EcoRI restriction sites).
###end p 29
###begin p 30
###xml 178 181 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c6">6</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c16">16</xref>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c22">22</xref>
###xml 377 382 <span type="species:ncbi:9606">human</span>
When the stringency for the identification of redundant sequences was reduced to 93% then only 15 702 sequences were classified as unique. However, we have previously found that NotI flanking sequences originating from different chromosomes can have 95-100% identity over >700 bp (6,16,22). Therefore, to exclude the possibility of removing unique flanks we defined the unique human subset to include the 22 551 sequences identified with more stringent criteria.
###end p 30
###begin p 31
The sequence set covered a total of 16 213 509 bp with an average sequence length of 720 bp. After sequencing, 0.3% (55 144 cases) of all nucleotides were reported as ambiguous (N). Comparisons between multiple sequencing reactions of the same clones indicated a sequencing accuracy of at least 98.5% over the first 160 bp. The sequence accuracy varied among clones with a negative relation to overall CG content and fluctuated along the sequence length. The achieved sequence fidelity was appropriate for the study as a short length cut-off for matching sequences was used (see Materials and Methods).
###end p 31
###begin p 32
###xml 88 91 88 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf428tb1">1</xref>
###xml 459 462 459 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 530 533 530 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 668 671 668 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 798 801 798 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 957 958 957 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c1">1</xref>
###xml 985 988 985 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 1143 1146 1143 1146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 310 315 <span type="species:ncbi:9606">human</span>
###xml 416 421 <span type="species:ncbi:9606">human</span>
###xml 729 734 <span type="species:ncbi:9606">human</span>
###xml 852 857 <span type="species:ncbi:9606">human</span>
###xml 943 948 <span type="species:ncbi:9606">human</span>
The repeat masking procedure (see Materials and Methods) identified 7227 (32.0%) of the NotI sequences as containing known repeats (Table 1). The repeats comprise 1 066 657 bp or 6.6% of the 16.2 Mb total and 20% of the total sequence from the repeat-containing clones. Comparison of these data with the draft human genome sequence revealed striking differences. All interspersed repeats occupied 44.8% of the total human genome sequence but only 4.7% of the NotI flanks. Alu repeats were present 6.6 times less frequently in the NotI sequences, while for LINE repeats this difference was almost 14-fold. Simple sequence repeats were also deficient in the vicinity of NotI sites (0.54 versus 3%). On the other hand, the youngest human LINE1 elements (L1Hs) represented 0.5% of all LINE elements in NotI flanking sequences compared to 0.1% in the total human genome. L1Hs are the only inter spersed repeats that still actively transpose in the human genome (1). One possibility is that NotI flanking sequences are located in actively transcribed chromosomal regions and therefore are available for transposition. However, sequences surrounding NotI sites may not tolerate such insertions and thus the older inserted elements were eliminated during evolution.
###end p 32
###begin p 33
###xml 103 106 103 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf428f1">1</xref>
###xml 208 211 208 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
To estimate the influence of repeats on the sequence analysis results, we compared masked and unmasked NotI sequences with the RefSeq nucleotide and protein databases (Fig. 1). The presence of repeats in the NotI flanking sequences does not impact on the analysis results with stringent comparison criteria. In fact, only under the relaxed stringency (e.g. 60% similarity over 50 bp) do repeats influence the results dramatically. All further analyses utilized masked sequences.
###end p 33
###begin title 34
###xml 6 9 6 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 45 50 <span type="species:ncbi:9606">human</span>
Using NotI sequences to verify the assembled human genome sequences
###end title 34
###begin p 35
###xml 457 458 457 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c2">2</xref>
###xml 56 61 <span type="species:ncbi:9606">human</span>
Several data collections have been compared against the human genome (euchromatic) assembly to estimate sequence coverage, including the RefSeq cDNA database, the set of STS markers, the set of radiation hybrid markers and randomly produced raw sequences. The public consortium estimated the draft genome sequence covered 88-90% (together with other public databases up to 94%) of the genome and Celera estimated that their draft sequence contained 91-99% (2).
###end p 35
###begin p 36
###xml 28 31 28 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 115 118 115 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 196 199 196 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 280 283 280 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
The inclusion of the set of NotI sequences can be used to assess the coverage of the draft sequences. Unmethylated NotI sites from the CBMI-Ral-STO cell line were anticipated to be present in the NotI clone grids, while the HTGS database contains both methylated and unmethylated NotI sites.
###end p 36
###begin p 37
###xml 33 34 33 34 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c1">1</xref>
###xml 35 36 35 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c2">2</xref>
###xml 76 79 76 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 107 108 107 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf428f2">2</xref>
###xml 149 152 149 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 335 338 333 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 410 413 408 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 611 614 605 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 635 638 629 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 739 742 733 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 798 799 792 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c6">6</xref>
###xml 800 802 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c16">16</xref>
###xml 10 15 <span type="species:ncbi:9606">human</span>
###xml 221 226 <span type="species:ncbi:9606">human</span>
The draft human genome sequence (1,2) contains a significant portion of the NotI sequence collection (Fig. 2). With stringent criteria, 55.7% of the NotI flanking sequences were present in a recent public assembly of the human genome (December 2001, identity >/=90%). Inclusion of the Celera sequences identified an additional 1.5% of NotI flanks. All public databases (EMBL + HTGS + EST) matched 89.2% of the NotI flanking sequences and search stringency is important here: this number increased to 91.1% at identity >/=78% and went down to 84.1% at identity >/=95%. The public draft sequence contained 19 552 NotI sites (i.e. 39 104 NotI flanking sequences). The EMBL coverage is misleading, as the EMBL database contains more than 4500 NotI flanking sequences generated in the previous studies (6,16).
###end p 37
###begin p 38
###xml 61 62 61 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c3">3</xref>
###xml 63 64 63 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c4">4</xref>
###xml 155 158 155 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 206 211 206 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c13">13</xref>
###xml 228 231 228 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 287 290 287 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 331 334 331 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 386 389 386 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 428 431 428 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 448 451 448 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 492 495 492 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 528 529 528 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf428tb2">2</xref>
###xml 564 567 564 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 605 608 605 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 693 696 693 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 851 854 851 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 909 912 909 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
Comparison with the complete chromosome 21 and 22 sequences (3,4) revealed several interesting features. The assembled chromosome 21 sequence contains 122 NotI sites (methylated and unmethylated). Ichikawa et al. (13) cloned 40 NotI sites and it was sufficient to construct the complete NotI restriction map. This map contained 43 NotI fragments but, using incomplete digestion with 40 NotI clones, it was possible to order all NotI fragments. The NotI flanking sequence database contains 49 NotI sites for chromosome 21 (Table 2). Altogether, out of 390 possible NotI sites on chromosomes 21 and 22, the NotI database contains 168 (43%) sites. From our data we can conclude that unmethylated NotI sites represent at least 43%. Eighteen clones that were identified in our work (5%) were present in public sequences with one nucleotide mismatch in the NotI site. Thus these clones either represent polymorphic NotI sites or result from sequencing errors in the public data.
###end p 38
###begin p 39
###xml 107 110 107 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c15">15</xref>
###xml 185 188 185 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 420 423 420 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 489 492 489 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 518 519 518 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c6">6</xref>
###xml 520 521 520 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c9">9</xref>
###xml 572 575 572 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 584 585 584 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c9">9</xref>
###xml 716 719 716 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 762 765 762 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 879 882 879 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 890 892 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c30">30</xref>
###xml 933 936 933 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 1028 1031 1028 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 1066 1069 1066 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 1217 1220 1217 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
Considering the redundancies in the draft genomic sequences and large differences in methylation status of NotI sites across cell lines (15) it is difficult to estimate the coverage of NotI flanks in this study. Based on the completed chromosome 21 and 22 sequences we can draw some conclusions. First, it was shown that chromosome 22 contains >2-fold more genes than chromosome 21, and we see the same ratio within the NotI flanking sequences. We have demonstrated that nearly all of the NotI clones contained genes (6,9) and suggested that 12.5-20% of all genes contain NotI sites (9). This correlates well with the number of genes on chromosomes 21 and 22 (168/770 = 22%). Second, the two chromosomes contain 390 NotI sites. Therefore, if we assume that each NotI site is associated with a gene (in reality we have shown that sometimes two genes are located close to the same NotI site; 30), then almost half of the genes contain NotI sites. This estimate appears excessive. We suggest that there are two distinct classes of NotI sites. The first group is 'live' NotI sites that are unmethylated or, more accurately, are not always methylated. They are located in CpG islands and associated with genes. The 'dead' NotI sites comprise the second group and they are (always) methylated and located outside functional CpG islands and genes. Further research is necessary to test this hypothesis.
###end p 39
###begin title 40
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
NotI sequences as a tool for gene identification
###end title 40
###begin p 41
###xml 100 101 100 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf428f3">3</xref>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c16">16</xref>
###xml 221 224 221 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
More stringent parameters were applied to the gene discovery pipeline than in the pilot study (Fig. 3; 16) (see Materials and Methods). A check against the SWISSPROT and TREMBL databases indicated that 23.2% of the total NotI flanking sequences were significantly similar to known proteins.
###end p 41
###begin p 42
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
Of the 22 551 unique NotI flanking sequences 48.7% were novel, as they were not previously present in the EMBL and EST databases. For these novel sequences, potential novel coding sequences were analyzed. Based on the stringent selection criteria 8.9% of the total sequences were identified with similarity to known proteins. Among the remaining 8972 novel clone sequences, 1649 (7.3%) sequences had identity of >78% to sequences in the EMBL and EST databases and 7323 (32.5%) clones were not similar to previously identified sequences.
###end p 42
###begin p 43
###xml 119 120 119 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf428f4">4</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c16">16</xref>
###xml 50 55 <span type="species:ncbi:9606">human</span>
Results of a sequence comparison with full-length human cDNA protein coding sequences from Unigene are shown in Figure 4A. As compared to results obtained in the pilot experiment (16) the portion with significant matches increased approximately2-fold.
###end p 43
###begin p 44
###xml 83 86 83 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 196 197 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf428f4">4</xref>
###xml 226 229 226 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 426 429 426 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 459 460 459 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c6">6</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c16">16</xref>
###xml 473 478 473 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 481 482 481 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c2">2</xref>
The number of sequences matching 5' and 3' ESTs is higher than the total number of NotI sequences that are likely to be expressed, e.g. 11.3% + 33.9% = 45.2% > 37.1% (for 90% similarity; see Fig. 4B). This is because the same NotI sequence can match 5' as well as 3' ESTs. These data further support a previous suggestion that many of the matching '3' EST' sequences are actually situated in the 5' ends of genes that contain NotI sites in their first exons (6,16). Venter et al. (2) extended these results for the entire genome and demonstrated a strong correlation between CpG islands and first coding exons.
###end p 44
###begin p 45
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 81 84 81 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 217 220 215 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 248 251 246 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 284 289 <span type="species:ncbi:9606">human</span>
To estimate how many NotI flanking sequences matched genes from other organisms, NotI sequences were compared to ESTs from all organisms. Several hundred additional ESTs (e.g. 661 for identity >/=78%) were similar to NotI flanking sequences. These NotI clones most likely represented human genes evolutionarily related to the genes from other organisms.
###end p 45
###begin p 46
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c1">1</xref>
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c5">5</xref>
###xml 538 539 538 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c1">1</xref>
###xml 540 542 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c31">31</xref>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c32">32</xref>
###xml 602 603 602 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c1">1</xref>
###xml 644 647 644 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 683 685 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c32">32</xref>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c33">33</xref>
###xml 825 828 825 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 863 866 863 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 956 957 956 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="gkf428tb3">3</xref>
###xml 992 997 992 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 1000 1001 1000 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c1">1</xref>
###xml 1111 1114 1111 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 1196 1199 1196 1199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 1367 1370 1367 1370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 1534 1537 1534 1537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 142 147 <span type="species:ncbi:9606">human</span>
It is well known that CpG islands are associated with genes and their most important feature is an absence of cytosine methylation (1,5). The human genome sequence data cannot discriminate between methylated and unmethylated cytosines. There are several algorithms for the identification of CpG islands on the basis of primary sequence. One quantitative definition holds that CpG islands are regions of DNA >200 bp long with a C+G content of >50% and a ratio of 'observed versus expected' frequency of CG dinucleotides which exceeds 0.6 (1,31,32). The ratio for the entire genome is approximately 0.2 (1). According to the previous data 82% of NotI sites are located in CpG islands (32,33). It is important to note that these data were obtained using either computational methods or limited experimental data sets. Using the NotI cloning method only unmethylated NotI sites can be isolated. An analysis of CG content for the first 350 bp is shown in Table 3. Comparing these data with Lander et al. (1), two main features are apparent: the fraction of sequences with >80% CG content is nine times higher in the NotI collection, i.e. 142 versus 22 sequences. Another striking finding is that even NotI flanking sequences with a CG content <50% have a very high ratio of observed versus expected frequency of CG dinucleotides (0.71). This suggests that essentially all NotI flanking sequences generated in the study are located in CpG islands and, therefore, the computational method misses at least 8.7% of CpG islands associated with NotI sites.
###end p 46
###begin p 47
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c28">28</xref>
###xml 145 148 145 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 535 536 535 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf428f5">5</xref>
###xml 560 563 560 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 204 209 <span type="species:ncbi:9606">human</span>
Regulatory regions, especially promoters, are negatively associated with the formation of nucleosomes (28). A total of 142 chromosome 3-specific NotI sequences for which 1 kb flanks were available in the human genome sequence (phase 3 'finished' sequence) were selected for an analysis of nucleosome formation potential (NFP). Positive NFP values indicate sequences that are likely to form nucleosomes efficiently, while negative scores indicate sequences likely to have poor nucleosome stacking ability. The results demonstrate (Fig. 5) that regions flanking NotI sites are less likely to form nucleosomes efficiently as their NFP values are below -1 and therefore resemble promoter regions in this feature.
###end p 47
###begin title 48
Conclusions
###end title 48
###begin p 49
###xml 91 92 91 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c1">1</xref>
###xml 93 94 93 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c2">2</xref>
###xml 77 82 <span type="species:ncbi:9606">human</span>
It should be emphasized that the enormous efforts deployed on sequencing the human genome (1,2) are extremely important, however, there remains a critical role for verified, integrated maps. In sequencing, the short and long repeats spread throughout the genome are sources of numerous errors. These errors are difficult to identify with a shotgun strategy, but they become evident when mapping information is combined with the sequence. Furthermore, difficulties in sequence assembly caused by the existence of large families of recently duplicated genes and pseudogenes are easier to resolve using integrated maps.
###end p 49
###begin p 50
In many cases, sequence and mapping information is duplicated, overlapping or contradictory. One must always keep in mind that even absolutely correct and long nucleotide sequences may be localized incorrectly along the chromosomal DNA if the appropriate accompanying mapping information is ignored. For this reason, in spite of the vast amount of information presently available, there is an urgent need to reconcile this information in a unified framework, to generate an integrated non-controversial map for each individual chromosome.
###end p 50
###begin p 51
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 187 190 187 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 408 409 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c6">6</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c17">17</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c22">22</xref>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c34">34</xref>
###xml 439 442 439 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 740 743 740 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 802 805 802 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 518 523 <span type="species:ncbi:9606">human</span>
###xml 582 587 <span type="species:ncbi:9606">human</span>
###xml 692 697 <span type="species:ncbi:9606">human</span>
###xml 796 801 <span type="species:ncbi:9606">human</span>
We believe that the NotI flanking sequences generated in this study will be helpful in verifying contig assemblies and in connecting orphan sequence contigs into a final genome assembly. NotI clones can serve as STSs that can be mapped precisely using PFGE and FISH. These flanking sequences have already been helpful in the isolation and mapping of new genes and resolving ambiguities in chromosome 3 maps (6,17-22,34). We think that the NotI clones will also be helpful as probes to close existing gaps in the draft human genome sequence and in estimating the completeness of the human genome sequence due to the independent approach used in this study. The data demonstrate that the draft human genome sequence has a strong bias against NotI flanking sequences, as a significant number of the human NotI sequences were not detected.
###end p 51
###begin p 52
###xml 77 80 77 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 164 167 164 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 270 271 270 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c6">6</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c34">34</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c35">35</xref>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c35">35</xref>
###xml 596 598 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c37">37</xref>
###xml 779 782 779 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 1073 1076 1073 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 1230 1233 1230 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 1302 1304 1302 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c22">22</xref>
###xml 1320 1323 1320 1323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 1464 1467 1464 1467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 114 119 <span type="species:ncbi:9606">human</span>
###xml 960 965 <span type="species:ncbi:9606">human</span>
###xml 1537 1542 <span type="species:ncbi:9606">human</span>
Several explanations can be offered to account for the low representation of NotI flanking sequences in the draft human genome sequences. We have cloned all of the NotI sites and constructed a physical map for two chromosome 3 regions containing tumor suppressor genes (6,34,35; A.I.Protopopov, V.I.Kashuba, V.Zabarovska, O.Muravenko, M.I.Lerman, G.Klein and E.R.Zabarovsky, unpublished results). In the course of these studies it became apparent that large-insert vectors from these regions were unstable and sensitive to deletions and rearrangements and that the original map was erroneous (35-37; A.I.Protopopov, V.I.Kashuba, V.Zabarovska, O.Muravenko, M.I.Lerman, G.Klein and E.R.Zabarovsky, unpublished results; ). Thus one potential explanation is that the cloning of some NotI site-containing regions may be selected against in experiments with large-insert cloning vectors. Our experience has also proven that even in small-insert plasmid vectors some human sequences are more easy to clone than others. In our procedure, we directly selected for clones containing NotI sites, while in a shotgun sequencing approach such sequences could be under-represented. An alternative explanation, based on the observation that some NotI flanking sequences can have 100% identity over long DNA stretches (22), is that some NotI sites were incorrectly fused in the assembly process. Furthermore, our experience demonstrates that sometimes it is very difficult to read NotI flanking sequences because of the extremely high CG content. During human genome assembly such sequences would be eliminated as possessing low quality data. Further experimental analysis is needed to conclusively identify the cause(s) of the bias.
###end p 52
###begin p 53
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 197 200 197 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
The results of this work show that NotI flanking sequences are a rich source for identification of new genes. A difference in this study compared with the pilot experiment is the lower fraction of NotI sequences with protein similarity (23.2% now versus 51% in the pilot study), resulting from more stringent analysis criteria. The comparatively high level of sequence errors (1.5% for the first 160 bp) is likely to be a consequence of the CG-rich stretches of DNA. In some cases CG content exceeded 95% over 100 bp. However, the sequencing accuracy does not affect the main results of the study, as short matches were used for searches. Moreover, lower stringency criteria for searches (25% for proteins and 75-78% for DNA) did not significantly alter the results.
###end p 53
###begin p 54
###xml 53 56 53 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 244 247 244 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 71 76 <span type="species:ncbi:9606">human</span>
###xml 208 213 <span type="species:ncbi:9606">human</span>
It is difficult to precisely determine the number of NotI sites in the human genome and the unmethylated portion in any particular cell type. Our rough estimation (based on chromosomes 21 and 22) is that the human genome contains 15 000-20 000 NotI sites, of which 6000-9000 are unmethylated in a subset of cells.
###end p 54
###begin p 55
###xml 380 385 380 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 388 389 388 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c2">2</xref>
The detection of CpG islands is difficult using only sequence data, as evidenced by existing computational methods missing a significant fraction of functional CpG islands. We conclude that unmethylated DNA stretches with a high frequency of CpG dinucleotides can be found in regions with low CG content. This conclusion is consistent with the surprising deduction made by Venter et al. (2): significantly more genes than expected are located in DNA regions with low CG content. This suggests that computational identification of CpG islands will improve if more weight is placed on the ratio of observed versus expected frequency of CG dinucleotides, rather than overall CG content.
###end p 55
###begin p 56
###xml 63 66 63 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 124 129 <span type="species:ncbi:9606">human</span>
###xml 176 181 <span type="species:ncbi:9606">human</span>
In summary, this work has demonstrated that sequences flanking NotI restriction sites can be used to complement large-scale human genome sequencing. As the organization of the human genome and that of other mammals is similar, this approach will contribute to the success of future sequencing projects.
###end p 56
###begin title 57
Figures and Tables
###end title 57
###begin p 58
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 56 57 56 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 92 93 92 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
 Similarity between unmasked/masked NotI sequences and (A) the RefSeq nucleotide database, (B) the RefSeq protein database.
###end p 58
###begin p 59
###xml 13 16 13 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
 Fraction of NotI flanking clones present in the EMBL, EST and HTGS databases (similarity >/=90% over 50 bp).
###end p 59
###begin p 60
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
NotI flanking sequences general analysis scheme.
###end p 60
###begin p 61
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 59 60 59 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 66 69 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 96 97 96 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 29 34 <span type="species:ncbi:9606">human</span>
 Similarity between NotI and human Unigene mRNA sequences (A) and NotI and expressed sequences (B).
###end p 61
###begin p 62
###xml 12 15 12 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf428c28">28</xref>
###xml 75 78 75 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
 The NFP of NotI flanking sequences calculated as in Levitsky et al. (28). NotI sites are located at position 0. Negative scores indicate sequences likely to have poor nucleosome stacking ability.
###end p 62
###begin title 63
Summary of repeat content
###end title 63
###begin title 64
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
Comparison of NotI flanking sequences with finished sequences of chromosomes 21 and 22
###end title 64
###begin p 65
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aSites with surrounding 1 kb were considered.
###end p 65
###begin p 66
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
bSimilarity 90%, length 50 bp, homology region includes NotI sites.
###end p 66
###begin title 67
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
GC content of NotI flanks
###end title 67
###begin title 68
ACKNOWLEDGEMENTS
###end title 68
###begin p 69
###xml 434 439 <span type="species:ncbi:9606">Human</span>
This work was supported by research funds from Pharmacia Corp. to the Center for Genomics and Bioinformatics, as well as grants from the Swedish Cancer Society, The Swedish Research Council, the Ingabritt och Arne Lundbergs Foundation, The Royal Swedish Academy of Sciences, the Karolinska Institute, The Swedish Foundation for International Cooperation in Research and Higher Education (to A.S.K.) and partly by the Russian National Human Genome Program (grants to O.V.M. and L.L.K.).
###end p 69
###begin title 70
REFERENCES
###end title 70

